Richard Ginn - 01 Jan 2026 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role: Chief Technology Officer, Director
Signature: /s/ Richard Ginn
Issuer symbol: TNON
Transactions as of: 01 Jan 2026
Net transactions value: -$44,111
Form type: 4
Filing time: 05 Jan 2026, 20:51:28 UTC
Previous filing: 15 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GINN RICHARD	Chief Technology Officer, Director	104 COOPER COURT, LOS GATOS	/s/ Richard Ginn	05 Jan 2026	0001896876

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNON	Common Stock	Options Exercise	$0	+126,577	+1966%	$0.000000	133,015	01 Jan 2026	Direct	F1
transaction	TNON	Common Stock	Tax liability	$44,111	-47,426	-36%	$0.9301	85,589	05 Jan 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNON	Restricted Stock Units	Options Exercise	$0	-126,577	-50%	$0.000000	126,577	01 Jan 2026	Common Stock	126,577		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents conversion of 126,577 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 126,577 shares of common stock of the Issuer on January 1, 2026.
F2	These shares were sold to pay tax liability associated with the vesting of RSUs.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.